Why hormones and ADHD are linked at all

The connection between ADHD and female hormones comes down to one crucial relationship: oestrogen influences dopamine. Dopamine is the neurotransmitter most central to ADHD — it underpins attention, motivation, working memory, and executive function, and ADHD is characterised by differences in dopamine signalling.

Oestrogen modulates the dopamine system: it affects dopamine synthesis, release, and receptor sensitivity across key brain regions including the prefrontal cortex. When oestrogen is high, dopamine activity tends to be enhanced; when oestrogen falls, dopamine availability drops with it. For a brain that already has a dopamine shortfall, a further hormone-driven decline can push symptoms from "managed" to "unmanageable."

This is why many women notice their ADHD symptoms fluctuate across the menstrual cycle — often worse in the low-oestrogen days before menstruation — and why the sustained oestrogen decline of perimenopause can have such a pronounced effect.

What happens in perimenopause

Perimenopause is the transitional phase — typically beginning in the early-to-mid forties and lasting several years — during which oestrogen levels become erratic and then progressively decline before menopause itself. Unlike the cyclical dips of the menstrual cycle, this is a longer, less predictable downward trend.

For women with ADHD (diagnosed or not), this hormonal shift frequently coincides with a marked worsening of symptoms:

Research by Camara and colleagues (2022) exploring women's experiences of ADHD across the reproductive lifespan documented exactly this: participants described hormonal transitions, including perimenopause, as periods when their symptoms intensified and their usual compensations failed.

Why so many women are diagnosed at this stage: Perimenopause is one of the most common points of ADHD diagnosis in women. For decades, effortful masking and coping strategies masked the underlying condition. When falling oestrogen removes the dopaminergic "buffer" those strategies depended on, the ADHD becomes visible — often for the first time — and women finally seek answers. The diagnosis frequently reframes not just the present crisis but a whole life.

The overlap that causes confusion

A significant problem is that perimenopause symptoms and ADHD symptoms overlap heavily — brain fog, poor concentration, forgetfulness, mood changes, and disrupted sleep appear in both. This overlap cuts two ways.

Some women have their genuine ADHD dismissed as "just menopause" or "just stress." Others are told their difficulties are purely hormonal when in fact a lifelong, previously-unrecognised ADHD has been unmasked. Epperson and colleagues have highlighted how oestrogen withdrawal affects prefrontal cognitive function in ways that are especially consequential for women who are already vulnerable to executive dysfunction — underscoring that hormones and ADHD are not competing explanations but interacting ones.

It is not "either/or": A woman can be perimenopausal and have ADHD, with each amplifying the other. Recognising both — rather than forcing the picture into a single cause — is what leads to effective support. If your difficulties are lifelong but have recently become far worse, that pattern points toward underlying ADHD unmasked by hormonal change.

Have your symptoms suddenly become harder to manage?

Our free assessment screens for the ADHD traits most often unmasked in women during hormonal transitions. Results in 10–35 minutes.

Take the free assessment →

What helps

Support is most effective when it addresses both the ADHD and the hormonal context. The following are areas commonly discussed by clinicians working in this space — but decisions about medication and hormone treatment must always be made with a qualified doctor.

Getting an accurate ADHD assessment

If ADHD has never been formally identified, an assessment is the foundation. Understanding that a neurological condition — not a personal failing or simply ageing — underlies the difficulties is often the single most validating and useful step.

ADHD treatment

Stimulant and non-stimulant ADHD medications work on the dopamine and noradrenaline systems and can substantially help symptoms that have worsened with falling oestrogen. Some women and clinicians observe that medication needs and responses change across the hormonal transition, which is worth discussing with a prescriber.

Hormonal considerations

Hormone replacement therapy (HRT) is a decision for a woman and her doctor, made on the basis of her overall health. Because oestrogen influences dopamine, some clinicians and researchers are interested in how hormonal treatment interacts with cognitive and ADHD symptoms during perimenopause — but the evidence base is still developing, and this is emphatically not something to self-prescribe. Speak to a GP or menopause specialist.

Reducing load and self-compassion

Practical strategies that help ADHD generally — externalising reminders, reducing demands, protecting sleep, and building in recovery time — matter even more during a period when internal resources are stretched. So does letting go of the belief that you "should" be able to cope as you once did; the ground has genuinely shifted beneath you.

If this resonates — what to do next

If you are in your forties or fifties and feel that abilities you once had are slipping — and especially if, looking back, the signs were there all along but manageable — it is worth exploring whether ADHD is part of the picture. ADHD in women is chronically underdiagnosed, and hormonal transitions are one of the moments it most often finally surfaces.

Our free screening assessment can help you understand whether your traits align with an ADHD profile. The results are printable and can be brought to a GP appointment. For more, read ADHD symptoms in women and our guide to why women with ADHD are diagnosed late.

References